| Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer | | 2022 |
| Surgeon’s Neoadjuvan Therapy Approach in Gastric Cancer | | 2022 |
| Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study | | |
| End-of-life care of patients with esophageal or gastric cancer: decision making and the goal of care | | |
| Clinicopathological features and CT findings of papillary gastric adenocarcinoma | | |
| Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial | BMC Gastroenterology | 2022 |
| Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis | Journal of Surgical Oncology | |
| Gastric hydrodistension CT versus CT without gastric distension in preoperative TN staging of gastric carcinoma: analysis of single-center cancer registry | Scientific Reports | 2022 |
| Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines | Cancer Medicine | |
| ASO Author Reflections: Care Fragmentation in an Era of Centralization | Annals of Surgical Oncology | |
| Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis | Journal of Surgical Oncology | |
| Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer | Cancer Science | |
| Proton Therapy in the Management of Luminal Gastrointestinal Cancers: Esophagus, Stomach, and Anorectum | Cancers | 2022 |
| Patterns and Impact of Fragmented Care in Stage II and III Gastric Cancer | Annals of Surgical Oncology | |
| Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma | Journal of Pathology: Clinical Research | |
| Targeted microRNA Profiling in Gastric Cancer with Clinical Assessement | Balkan Journal of Medical Genetics | 2021 |
| Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management | European Journal of Nuclear Medicine and Molecular Imaging | |
| Surgery is Associated With Improved Overall Survival in Patients With Metastatic Gastric Cancer: A National Cancer Database Analysis | American Surgeon | |
| The Association of Race With Adequate Lymph Node Evaluation for Gastric Cancer. | American Surgeon | 2022 |
| Current and future imaging modalities in gastric cancer. | Journal of Surgical Oncology | 2022 |
| The future of endoscopic resection for early gastric cancer. | Journal of Surgical Oncology | 2022 |
| Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant Treatment. | Current Treatment Options in Oncology | 2022 |
| Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma | Tomography | 2022 |
| [Topographic and anatomical landmarks for endoscopic navigation in surgery for complicated gastric cancer]. | Khirurgiya | 2022 |
| Table_1.docx | | 2020 |
| Data_Sheet_2.docx | | 2019 |
| Data_Sheet_1.docx | | 2019 |
| An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic. | Expert Opinion on Drug Discovery | 2022 |
| Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients | Cancer | 2021 |
| Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. | Biomedicines | 2021 |
| Advanced Endoscopic Resection Techniques: Endoscopic Submucosal Dissection and Endoscopic Full-Thickness Resection. | Digestive Diseases and Sciences | 2022 |
| Quality performance indicators for the surgical treatment of gastric adenocarcinoma: a systematic review. | ANZ Journal of Surgery | 2022 |
| The New Era of Immunotherapy in Gastric Cancer. | Cancers | 2022 |
| Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers. | Cancer | 2022 |
| Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study. | Digestive Diseases and Sciences | 2022 |
| Targeting mitochondria as a therapeutic anti-gastric cancer approach. | Apoptosis: an International Journal on Programmed Cell Death | 2022 |
| Detection of secondary upper gastrointestinal tract cancer during follow-up esophagogastroduodenoscopy after gastrectomy for gastric cancer | Annals of Gastroenterological Surgery | |
| Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein-Barr Virus-Associated Gastric Cancer. | Frontiers in Oncology | 2021 |
| Pathologic Factors Associated with Low Risk of Lymph Node Metastasis in Nonmucinous Adenocarcinoma of the Appendix. | Annals of Surgical Oncology | 2022 |
| Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy. | Annals of Surgical Oncology | 2022 |
| Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series. | Annals of Surgical Oncology | 2022 |
| Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study. | Frontiers in Oncology | 2021 |
| Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma. | Journal of Cancer Research and Clinical Oncology | 2022 |
| ASO Author Reflections: Risk Factors for Lymph Node Metastasis in Non-mucinous Adenocarcinoma of the Appendix. | Annals of Surgical Oncology | 2022 |
| Venous Invasion Is a Risk Factor for Recurrence of pT1 Gastric Cancer with Lymph Node Metastasis. | Journal of Gastrointestinal Surgery | 2022 |
| The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers. | Frontiers in Oncology | 2021 |
| Symptomatic Recurrence and Survival Outcomes After Curative Treatment of Gastric Cancer: Does Intensive Follow-up Evaluation Improve Survival? | Annals of Surgical Oncology | 2021 |
| Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment. | World Journal of Gastrointestinal Surgery | 2021 |
| Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National Cancer Database | BMJ Open Gastroenterology | 2020 |
| Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma | Clinical Case Reports (discontinued) | 2021 |
